Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Calculi Dissolution Agent [EPC]
Tromethamine is an alkalizing agent and biological buffer used to treat metabolic acidosis, particularly during cardiac surgery or cardiac arrest. It belongs to the class of calculi dissolution agents and acts as a proton acceptor to neutralize metabolic acids.
Name
Tromethamine
Raw Name
TROMETHAMINE
Category
Calculi Dissolution Agent [EPC]
Drug Count
4
Variant Count
5
Last Verified
February 17, 2026
RxCUI
198412
UNII
023C2WHX2V, H4N855PNZ1, XF417D3PSL, PQ6CK8PD0R, QN83US2B0N, G63QQF2NOX, PWZ1720CBH, 1P9D0Z171K, 3XUS85K0RA, O4M0347C6A, 71DD5V995L, 0A5MM307FC, I670DAL4SZ, 92RU3N3Y1O, 5EM498GW35, PDC6A3C0OX, 9KJL21T0QJ, 0RBV727H71, 4Y5P7MUD51, 4X49Y0596W, 5A68WGF6WM, HIE492ZZ3T, B697894SGQ, 6DC9Q167V3, ETJ7Z6XBU4, 15FIX9V2JP, 059QF0KO0R, R0ZB2556P8
About Tromethamine
Tromethamine is an alkalizing agent and biological buffer used to treat metabolic acidosis, particularly during cardiac surgery or cardiac arrest. It belongs to the class of calculi dissolution agents and acts as a proton acceptor to neutralize metabolic acids.
Detailed information about Tromethamine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Tromethamine.
Tromethamine, chemically known as tris(hydroxymethyl)aminomethane and often referred to by the acronym THAM, is a highly specialized alkalizing agent and biological buffer. It is primarily utilized in clinical settings to correct metabolic acidosis, a condition characterized by an excess of acid in the body's fluids. Unlike traditional alkalizing agents such as sodium bicarbonate, Tromethamine is a non-sodium-based proton acceptor that can effectively cross cell membranes to neutralize both intracellular and extracellular acids.
Tromethamine belongs to a class of medications known as alkalizing agents, and more specifically, it is categorized as a Calculi Dissolution Agent [EPC] when used in specific urological contexts. It was first approved by the U.S. Food and Drug Administration (FDA) in the 1960s and has since remained a critical tool in the management of acute acid-base imbalances, particularly those occurring during cardiac bypass surgery or following cardiac arrest. Because it does not contain sodium, it is often preferred in patients who are sodium-restricted or those experiencing fluid overload. Only your healthcare provider can determine if Tromethamine is right for your specific condition.
To understand how Tromethamine works, one must understand the chemistry of acid-base balance. Metabolic acidosis occurs when the body produces too much acid or the kidneys are not removing enough acid. This leads to a drop in blood pH. Tromethamine acts as a weak base (pKa 7.8 at 37°C) that combines with hydrogen ions (H+) to form a cationic salt.
At the molecular level, Tromethamine acts as a proton acceptor. When injected into the bloodstream, it reacts with carbon dioxide (CO2) to form bicarbonate and with metabolic acids (like lactic acid) to neutralize them. A unique feature of Tromethamine is that it does not generate carbon dioxide during the neutralization process. In contrast, sodium bicarbonate reacts with acid to produce CO2, which must then be eliminated by the lungs. This makes Tromethamine particularly useful in patients with impaired respiratory function who cannot easily exhale excess CO2. Furthermore, because it is an organic amine, a portion of the dose remains un-ionized at physiological pH, allowing it to penetrate cell membranes and buffer the acidic environment inside the cells themselves.
The pharmacokinetics of Tromethamine are straightforward but necessitate careful monitoring by medical professionals.
Tromethamine is FDA-approved for several critical indications, primarily focused on the rapid correction of systemic acidity:
Tromethamine is available as a sterile, non-pyrogenic solution for intravenous infusion. It is typically supplied in a 0.3 Molar concentration (approximately 36 grams per liter). It is often packaged in large-volume glass or plastic containers (e.g., 500 mL) intended for slow infusion or rapid bolus depending on the clinical urgency. There are no oral tablet or capsule forms of Tromethamine available due to its chemical properties and the acute nature of the conditions it treats.
The dosage of Tromethamine is not fixed; it must be calculated individually for each patient based on the severity of their acidosis and their body weight. The standard method for determining the dose involves measuring the "base deficit" through an arterial blood gas (ABG) test.
The general formula used by clinicians is:
For example, if a 70 kg patient has a base deficit of 10 mEq/L, the calculated dose would be approximately 770 mL of the 0.3 M solution. However, clinicians usually limit the initial dose to 500 mg/kg (about 14 mL/kg for a 0.3 M solution) over a period of not less than one hour to avoid rapid shifts in pH or electrolytes. In emergency situations like cardiac arrest, a dose of 3.6 to 10.8 grams (100 to 300 mL) may be administered rapidly into a large peripheral vein.
Tromethamine use in children, particularly neonates, is highly specialized. The dosage is calculated using the same base-deficit formula as adults, but the total dose is often capped more strictly to prevent complications like hypoglycemia or respiratory depression. In neonates, the dose is usually limited to the amount required to bring the pH to 7.2 or 7.3, rather than a full correction to 7.4. It is critical that pediatric administration occurs only in a neonatal or pediatric intensive care unit (NICU/PICU) with continuous monitoring.
Since Tromethamine is excreted entirely by the kidneys, patients with renal failure or significant impairment require extreme caution. In cases of anuria (no urine production) or severe uremia, the drug is generally contraindicated. If it must be used, doses are significantly reduced, and the patient may require dialysis to remove the drug and its salts from the system.
No specific dosage adjustments are required for patients with liver disease, as the drug is not metabolized by the liver. However, these patients often have complex acid-base and fluid balance issues that require careful monitoring.
Elderly patients are more likely to have decreased renal function. Therefore, dose selection should be conservative, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.
Tromethamine is strictly for intravenous use and must be administered by a healthcare professional in a hospital setting.
Because Tromethamine is administered by healthcare professionals in an acute care or surgical setting, a "missed dose" in the traditional sense is unlikely. If an infusion is interrupted, the clinical team will reassess the patient's blood gas levels to determine if further treatment is necessary.
An overdose of Tromethamine can lead to severe alkalosis (blood becoming too basic), respiratory depression, and life-threatening electrolyte imbalances.
Because Tromethamine is an IV medication used in critical care, side effects are often related to the rapid shift in chemistry rather than the drug itself.
> Warning: Stop taking Tromethamine and call your doctor immediately if you experience any of these.
Tromethamine is intended for short-term, acute use. It is not used for chronic management of acidosis. Therefore, long-term side effects are not well-documented. However, repeated use in a short period can lead to persistent electrolyte imbalances or damage to the veins used for infusion.
There are currently no FDA Black Box Warnings for Tromethamine. However, the drug carries significant "Warnings and Precautions" regarding respiratory depression and tissue damage that are treated with the same level of clinical gravity as a black box warning.
Report any unusual symptoms to your healthcare provider. Medical staff will monitor you closely during the entire duration of the infusion to ensure safety.
Tromethamine is a potent alkalizing agent that should only be used by clinicians experienced in acid-base management and in facilities equipped with advanced monitoring and life-support systems. The most critical safety concern is the potential for respiratory depression. Because Tromethamine neutralizes CO2 and increases pH, it can suppress the respiratory center in the brain, leading to a decrease in the urge to breathe. This can be fatal if the patient is not closely monitored or supported with mechanical ventilation.
No FDA black box warnings for Tromethamine.
Patients receiving Tromethamine require intensive monitoring, including:
Tromethamine is administered in a hospital or surgical setting to patients who are acutely ill. Therefore, driving or operating machinery is not applicable during treatment. Following recovery, patients should consult their doctor regarding when it is safe to resume these activities.
There is no direct interaction between alcohol and Tromethamine; however, alcohol consumption can worsen metabolic acidosis and impair liver/kidney function, making the management of the underlying condition more difficult. Alcohol should be avoided during the recovery phase.
Tromethamine is discontinued once the target blood pH is reached or if the patient develops adverse reactions. There is no "withdrawal syndrome" associated with Tromethamine, but the underlying cause of the acidosis must be addressed to prevent the condition from returning.
> Important: Discuss all your medical conditions with your healthcare provider before starting Tromethamine.
There are few absolute contraindications for drug combinations with Tromethamine, but it should never be mixed in the same IV line with certain medications:
Since Tromethamine is an IV drug used in acute care, food interactions are generally not a concern. However, patients on a high-protein diet may have a higher baseline acid load, which could theoretically require higher doses of Tromethamine. This is managed by the clinician through blood gas monitoring.
Tromethamine will directly affect the results of:
For each major interaction, the mechanism is usually related to the change in blood or urine pH (pharmacodynamic interaction) or the stimulation of insulin release. Management involves frequent lab testing and adjusting the doses of the interacting medications.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Tromethamine must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
There are no well-documented cross-sensitivities between Tromethamine and other common drug classes. However, patients who are sensitive to other organic amine buffers should be treated with caution.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Tromethamine.
Tromethamine is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether Tromethamine can cause fetal harm when administered to a pregnant woman. It should be given to a pregnant woman only if clearly needed. The primary concern is the potential for rapid shifts in maternal pH and electrolytes to affect the fetus. If used during labor or delivery, the newborn must be monitored closely for respiratory depression and hypoglycemia.
It is not known whether Tromethamine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Tromethamine is administered to a nursing woman. Given that Tromethamine is used for acute, life-threatening conditions, breastfeeding is usually interrupted during the period of acute illness and treatment.
Tromethamine has been used in infants and children for the correction of metabolic acidosis. However, it is not the first-line treatment and is reserved for cases where sodium bicarbonate is inappropriate. In neonates, there is a specific risk of "hemorrhagic liver necrosis" if the drug is infused too rapidly or through an improperly placed umbilical vein catheter. Pediatric patients also have a much higher risk of developing severe hypoglycemia following Tromethamine administration.
Clinical studies of Tromethamine did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently from younger subjects. However, because elderly patients are more likely to have decreased renal function, the risk of toxic reactions to this drug is greater. Clinicians typically use lower doses and monitor kidney function (Creatinine Clearance) more frequently in this population.
In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, Tromethamine is generally avoided. If the GFR is between 30 and 60 mL/min, the dose should be reduced by at least 50%, and the patient must be monitored for signs of alkalosis and hyperkalemia. Dialysis is effective at removing Tromethamine if toxicity occurs.
While the liver does not metabolize Tromethamine, patients with severe liver impairment (Child-Pugh Class C) often have associated renal issues (hepatorenal syndrome) and complex acid-base disturbances. In these patients, the risk of fluid overload and electrolyte shifts is magnified.
> Important: Special populations require individualized medical assessment.
Tromethamine (THAM) is an organic amine with a pKa of 7.8. Its primary mechanism of action is as a biological buffer and proton acceptor. In the presence of metabolic acids, Tromethamine reacts as follows:
This reaction removes hydrogen ions from the blood, effectively raising the pH. Additionally, it reacts with dissolved CO2 to form bicarbonate (HCO3-). Unlike sodium bicarbonate, which requires the lungs to exhale the CO2 produced by the buffering reaction, Tromethamine actually reduces the partial pressure of CO2 (pCO2) in the blood. This makes it uniquely effective in mixed metabolic and respiratory acidosis.
The onset of action is immediate upon intravenous administration. The duration of effect depends on the underlying cause of the acidosis and the patient's renal function. Tromethamine also has a mild osmotic diuretic effect, which can help increase urine flow, further aiding in the excretion of the neutralized acid salts.
| Parameter | Value |
|---|---|
| Bioavailability | 100% (Intravenous) |
| Protein Binding | 0% |
| Half-life | 1.5 - 3 hours (Normal Renal Function) |
| Tmax | Immediate (IV) |
| Metabolism | None |
| Excretion | Renal (100% as salt) |
Tromethamine is classified as an alkalizing agent. It is often grouped with sodium bicarbonate and sodium lactate, although its chemical behavior as a proton acceptor distinguishes it from these traditional salts. In the context of urology, it is classified as a Calculi Dissolution Agent.
Medications containing this ingredient
Common questions about Tromethamine
Tromethamine, also known as THAM, is primarily used to treat metabolic acidosis, a condition where the blood becomes too acidic. It is most commonly used in emergency or surgical settings, such as during open-heart surgery or after a patient has suffered a cardiac arrest. Unlike other treatments, it can help lower acidity both inside and outside of cells without producing extra carbon dioxide. It is also occasionally used to help dissolve certain types of kidney stones by making the urine more alkaline. Because it is a potent medication, it is only administered by healthcare professionals in a hospital.
The most common side effects of Tromethamine include irritation or redness at the site where the IV is inserted. Because it changes the chemistry of the blood, it can also cause temporary shallow breathing (respiratory depression) as the body adjusts. Some patients may experience a drop in blood sugar levels (hypoglycemia) or changes in potassium levels. In rare cases, if the medication leaks out of the vein, it can cause severe tissue damage or skin burns. Medical staff will monitor your vital signs and blood levels closely during treatment to manage these risks.
Tromethamine is administered in a hospital for acute, often life-threatening conditions, so you will not be able to drink alcohol during treatment. Furthermore, alcohol can interfere with the body's acid-base balance and worsen the very condition Tromethamine is meant to treat. Alcohol can also put extra strain on the liver and kidneys, which are needed to process and clear the medication. Once you have recovered and are discharged, you should ask your doctor when it is safe to resume drinking alcohol. Generally, it is best to wait until your metabolic health has fully stabilized.
Tromethamine is considered an FDA Category C medication, meaning its safety during pregnancy has not been fully established through clinical trials. It is only used in pregnant women if the potential benefit to the mother outweighs the potential risk to the fetus, usually in life-saving situations. The main concern is that rapid changes in the mother's blood chemistry could affect the baby's stability. If it is used during labor, the newborn baby must be checked immediately for signs of low blood sugar or breathing problems. Always discuss the risks and benefits with your obstetrician and medical team.
Tromethamine begins to work almost immediately because it is injected directly into the bloodstream. As soon as the infusion starts, the molecules begin capturing excess hydrogen ions and neutralizing acids in the blood. Doctors can usually see improvements in blood pH levels on lab tests within minutes of starting the infusion. However, the total time required to fully correct the acid-base balance depends on the severity of the condition and the dose being given. The medical team will continue the infusion until the desired blood pH is achieved and stabilized.
Tromethamine is not a medication you take at home, so you cannot stop it yourself. It is given as a continuous or bolus IV infusion in a hospital. The medical team will stop the infusion once your blood gases show that your pH levels have returned to a safe range. There is no risk of withdrawal or "rebound" acidity from stopping the drug suddenly, but the underlying cause of the acidosis must be treated. If the original problem (like heart or kidney issues) isn't fixed, the acidity could return. Your doctor will determine the appropriate time to end the treatment.
Since Tromethamine is administered by trained medical professionals in a hospital setting, it is highly unlikely that a dose will be missed. The medication is typically given based on real-time lab results from blood tests. If an infusion is accidentally interrupted, the healthcare provider will immediately check your blood pH and restart the treatment if necessary. You do not need to worry about tracking doses as the hospital staff manages the entire administration process. If you have concerns about your treatment schedule, you should discuss them with your attending physician or nurse.
Tromethamine does not cause weight gain in the traditional sense of increasing body fat. However, because it is delivered as an intravenous fluid, it can lead to temporary fluid retention or "water weight" in some patients. This is especially true for patients with heart or kidney problems who may have difficulty processing the extra fluid volume. This fluid weight usually disappears once the treatment is finished and the body eliminates the extra water through urine. It is not used long enough to cause any permanent changes in body weight or metabolism.
Tromethamine can interact with several other medications, which is why your doctor must know your full medical history. It can particularly interact with drugs that affect potassium levels, such as certain diuretics, or medications that lower blood sugar, like insulin. It can also change how quickly your kidneys get rid of other drugs like aspirin or amphetamines by changing the acidity of your urine. Because of these risks, Tromethamine is often given through its own dedicated IV line to prevent it from mixing with other drugs. Your medical team will carefully coordinate all your medications during treatment.
Yes, Tromethamine is available as a generic medication, often simply labeled as Tromethamine Injection or THAM. Generic versions are required by the FDA to have the same quality, strength, and purity as the original brand-name version. Because it is a specialized hospital drug rather than a prescription you fill at a pharmacy, you likely won't have a choice between brand and generic; the hospital will use the version they have in stock. Both versions are equally effective at treating metabolic acidosis when administered correctly by a healthcare professional.